>PROKKA_00001 Botulinum neurotoxin type F precursor
MMPERYNNALNHYYRKEYYVIDYFKNYNINGFKNGQIKTKLPLSKYNKEIINKPELIVNL
INQNNTVLMKSNIYGDGLKGTVDNFYSNYIIPYNLNYEHSINYSYLDNVNIEEIEKIPPI
NDEDIYPYRKNADTFIPVYNITKAKEINTTTPLPINYLQAQMIDSNDINLSSDFLKVISS
KGSLVYSFLNNTMDYLEFIKYDKPIDTDKKYYKWLKAIFRNYSLDITETQEISNQFGDTK
IIPWIGRALNILNTNNSFVEEFKNLGPISLINKKENITIPKIKIDEIPSSMLNFSFKDLS
ENLFNIYCKNNFYLKKIYYNFLDQWWTQYYSQYFDLICMASKSVLAQEKLIKKLIQKQLR
YLMENSNISSTNLILINLTTTNTLRDISNQSQIAINNIDKFFNNAAMCVFENNIYPKFTS
FMEQCIKNINKSTKEFILKCTNINETEKSHLIMQNSFSNLDFDFLDIQNMKNLFNSYTEL
LIKEQTSPYELSLYAFQEQDNNVIGDTSGKNTLVEYPKDIGLVYGINNNAIHLTGANQNI
KFTNDYFENGLTNNFSIYFWLRNLNQNTIKSRLIGSKEDNCGWEIYFENDGLVFNIIDSN
GNEKNIYLSNISNNSWHYIVISINRLKDQLLIFIDNILVANEDIKEILNIYSSDIISLLS
DNNNVYIEGLSVLNKTINSNEILTDYFSDLNNSYIRNFDEEILQYNRTYELFNYVFPEIA
INKIEQNNNIYLSINNENSLNFKPLKFKLLNTNPNKQYVQKWDEVIFSVLDGTEKYLDIS
TTNNRIQLVDNKNNAKIFIINNDIFISNCLTLTYNNVNVYLSIKNQDYNWVICDLNHDIP
KKSYLWILKNI*
>PROKKA_00002 Botulinum neurotoxin type E precursor
MPKINSFNYNDPVNDKTILYIKPGGCQQFYKSFNIMKNIWIIPERNVIGTIPQDFLPPTS
LKNGDSSYYDPNYLQSNEEKDRFLKIVTKIFNRINDNLSGGILLEELSKANPYLGNDNTP
NNQFHIGDASAVEIKFSNGSQSILLPTVIIMGAEPDLFETNSSNISLKNNYMPSNHGFGS
IAIVTFSPEYSFRFNDNSMNEFIQDPALTLMHELIHSLHGLYGAKGITTKYTITQQQNPL
ITNIRGTNIEEFLTFGGTDLNIITNAQSNDIYTNLLDDYKKIASKLSQVQVSNPQLNPYK
DVFQEKYGLDKDANGIYSVNINKFNDIFKKLYSFTEFDLATKFQVKCRKTYIGHHKYFRL
SDLLNDSIYNISDGYNINTLKVNFRGQNTNLNTRIITPITGRGVVRKIIRFCTNIFSPKG
IRKSICIEVNNGELFFVASENSYNDDNINTSKEIDDTVTSNNNYENDLDQVILNFNSESA
PGLSDEKLNLTIQDDAYIPKYDSNGTSDIEQYDVSELNVFFYLDAQKVPEGENNVDFTSS
IDTALLEQPKIYTFFSSKFISNLNKTMQAALFVSWIQQVLVDFTTEATQKSTVDKIADIS
IVVPYIGLALNIGNEAQKGNFKDALELLGAGILLEFEPELLIPIILVFTIKSFLGSSDNK
NKVIKAINNALKERDENWKEVYSFIVSNWMTKINTQFNKRKEQMYQALQNQVNAIKTIIE
SKYNSYTLEEKNELKNKYDIEQIENELNQTVSIAMNNIEIFLTESSISYLMKLINEVKIN
KLKEYDENVKTYLLDYIIKHGSILGESQQELNSMVIDTLNNSIPFKLSSYTDDKILISYF
NKFFKTIKSSSVLNMRYKNDKYIDTSGYDSNINIKGDVFIYPTNKNQFGIYNNKLSEVNI
SQNDYIIYDNKYKNFSISFWVRIPNYDNKIVNVNNEYTIINCMRDNNSGWKVSLNHNEII
WTLQDNAGINQKLVFKYGNANGISDYINKWIFVTITNDRLGDSKLYINGNLIDKKSILNL
GNIHVSDNILFKIVNCSYTRYIGMRYFNIFDKELDKTEIETLYNNEPNTNILKDFWGNYL
LYDKEYYLLNVLKPNNVIDSNRDSTFSIHNIRSTIVLANRLYSGIKVKIQRVNNSSTNDN
LVRKNDQVYINFVASKTHLFPLYADTNTTNKEKTIKSSSSGNRFNQVVVMNSVGNNCTMN
FKNNNGNNIGMLGFKDNTLVASTWYYTHMRDNTNSNGCFWNFISEEHGWQEK*
>PROKKA_00003 Helix-turn-helix domain protein
MNRNIIGKKVRIIRKAKNLTQEELIVRIQLKGLNINRPMLSRIETDSREVYDFKVKAIAE
ALDISVDELFIQN*
>PROKKA_00004 Replication-associated recombination protein A
MTPLAERMRPTKLEDFVGQKQIIGEGKPLYNIIKSKNIVNCILYGPPGTGKTTLANIMAN
YVDRKFYKLNATTASVKDIQEIASSLDTLLGYNGVVVYIDELQHFSKKQQQSLLEFIEKG
QITLIASTTENPYFVLHKAILSRCNIFTFKPLTTDDIKFGVVKAIERAIENGMEIKYTDD
AISYIAEISQGDYRKAYNILELGIISSLKRTLEITVEYIEELEQSHIRFDASGDEFYNSL
SALQKSIRGSDADAAIHYLARLTKSGNLTAIVRRLGVIVAEDIGLAHPNALTVVNSGLEL
VLKVGLPEAQLILSELVIYLATLPKSNSAYLAIKSAMQDLENKNVGDVPVHLKDAHYSSA
QKLGVGGYKYPHDYSNNYVKQKYMPQELRDTIYYIPQENKYEGSIKNYWKNIKE*
>PROKKA_00005 hypothetical protein
MGKVGRKENCNISDNDMLVALERYTREFPNEKINIKKLADFSGIERHYWYSRKGFREKIE
EINSISYEKYDIISDGDRKKIKFPNVDEVVDNNFRNKKRLKFILNSFFLTYQDFYESSCE
AYKLKKDINILKDKIIKYEDEIQKLKNERDKFRELSNYNENKYYEIAIRSRERNFRKENN
IKSNVIEINNKNIKAYSTDEDDLDSLLNRIDD*
>PROKKA_00006 hypothetical protein
MNNKQQYKLALREGLLVNQIANNSDSLVIVTKELKIYKEEELDYYKEKFNYFKKKGRIVN
CVFNDLIWTLSETDEGGYKSNRNIKFSINFINKNNIIKAYLINLLINLININTIVERVRV
VSDIINISNFFDIDKFNEFEEYIESTFDNNKLNMKDYTMNFISFIRDNVDEEYCNYLVSL
PNEYFSKTREIPDYTSILKFDFLLDKYLKNSDEKEFFRYYPIVLWWKICSKIPLRPCEFM
ILKKDCVYEKNRKYYIRIRRCKPHGFVNKALNIRKEQSFRINKEIYDLVMKVVSHKSHDC
EFLLSKNLYNKYYTQYTYKEELVQGRVMRSYNLDKCLKDFYYYEINNKNIQTVISKKDVK
ESLSQQFYRDCMVSLQLGDARHLAIINLVLQGTNSYLIREMCGHRDINSHLHYIDHAKTY
ITSKVLVLTDIRKLEIKLANIYSNESFEYGNKRNNKVSNLLYNEYKKVGDIYCKRYVGRK
EMFPFLCLTDCDECNDKVETDFTGNTDEEIKTNKMEIERQFQIIEKYLKDAQFNSIIDSK
NERVLFESQKNIEESANKLNYLISKEAELEAKIFFGGMITKEE*
>PROKKA_00007 hypothetical protein
MNKENVVIELEDAAKEINPKCYKYFMKKLKTLNNINIFDKNGKLFITKNDFEKLKRNKAS
KIPYHIDIPNGYASRNEAVKKYNINYNSLRHNEEKGIIKTAISGGIAFLEKESIEKHIEF
LKYIEKINNDDNWIKVSSLRGKAYYDRISYTVRRNDFKNDLIKIGIGRTAEFFITRKLYK
EIINGKHKIIVTSQHKKKILKDDIEGIITKLLIETGVNSIRQKAKMKQLIKVKEISELSG
IDYEEIIESRRYFNGEIVKEQNIEYMHRYDIENIMKNFGYYSIKKLSKICGISFSTLIRD
FNIANFLGIYINFKIDKDFFVDINGVEIILKEFSKNYIATLTLDEIYRERMKLFPDEFFK
TYKLADEFIVKKKRNCYRPYGEDTTSYNRVINSIENLVNYLDKEIFEYSAEELLKLVSNT
NIVKRGYQAHVCQFINYVKRKMRNDCEYNKVFGLTLLTQYKIEKGENYLEKIYDKETWSK
YYVLLKDIDKHIVNAIKDPRYAQSWLYCILNLSVTWRKKNIILSLPRIKLQEIGVYEFEW
FSSKNVFTYSMAELVLNQIKFSLDGVIAYKNRRHLHINIPMSLKIPTAIAFIICEIHCRE
KSKDNIMYELAQSYIRKSDYKKLFEDDKLLNFENLKCTRSIISYGFSHAINTIGTVPAAY
KIYSNRRSHSDSEQKITNVTGDHYIALDGIENGAKEFMFHVVERGAFGFMYYKLFKCFFD
KKDFENISQEQLTDLTKYSDQILNPRTLENIADKFIENDRINKLSIFEILWYSSIIKNKG
KRDLSSKSNIFLAIMIDLYKKQSEDLLGKSDEFKTFVDEKYLQLDAEIEDILKNKISTSK
IIDNILNGSNCCYSKDTNCIFDRIERKELCPYKYEDNGGKSCVGCKYNLLTVYALNEINE
KMQTLLDKIQKKSYFTKEEIQKNSYILKNYVSIILEASVHFKNEEFLSNYINLKMIKTKI
YKLKSEGKIINI*
>PROKKA_00008 hypothetical protein
VFIISNIIDLRNTNSKYRFKVKVCKYKREGRYEDHLFQKAIIVLFDNITGKSRVHEFTEF
AIREFGKNRIKTQVDYLGKLVKFLNYVIKNKVKKNFKYLDFYDVEEFLQEIALDVQLNTF
NIYKMVLSRFYRYLAQKEWLINVSINDFIIKESEKNGGVMINYDIPICNIDIPDNIYRRN
THVMEYELQAMLLEVAIEEVNIIALAIFFQMFGGLRSGEIVNLTHSAVQCIGPYGRYGML
LDITDRNLRLDLKNNQAKGYSKKSRKQKVISPFNMLEKIYIQHMKKYKCVDDSGAIFVNK
DGMPMTIGSYNYYFDKLKKIFLKRLKESDNPTLKVQGDILCAAKWKTHIGRGIFSNNLGE
FMSASELKIARGDKYINSSDSYIEETKKIGKLYEENAEGAFQLLIKKINE*
>PROKKA_00009 Replication-associated recombination protein A
MSPLADLMRPSKIEDFVGQRHILGKNTPLYNLIKSKKICNCIFYGPPGTGKTTLANIMAK
YVDKKFYKLNATTASVKDIQNITSELDNLLNYAGVVLYIDELC*
>PROKKA_00010 molybdenum cofactor biosynthesis protein MoaC/MOSC-domain-containing protein
MGECIMPTNGVFAKVIEGGQMKIGDEIEIASGIEKMY*
